ESPR - Esperion Therapeutics - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

ESPR is currently covered by 5 analysts with an average price target of $15.45. This is a potential upside of $12.41 (408.22%) from yesterday's end of day stock price of $3.04.

Esperion Therapeutics's activity chart (see below) currently has 241 price targets and 205 ratings on display. The stock rating distribution of ESPR is 90.91% BUY and 9.09% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 43.29% with an average time for these price targets to be met of 117.75 days.

Highest price target for ESPR is $4, Lowest price target is $3, average price target is $3.75.

Most recent stock forecast was given by JOSEPH PANTGINIS from HC WAINWRIGHT on 18-Sep-2025.

Currently out of the existing stock ratings of ESPR, 20 are a BUY (90.91%), 2 are a HOLD (9.09%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy

1 months 10 days ago
(18-Sep-2025)

0/2 (0%)

$16.92 (333.07%)

Buy

$4

$1.29 (47.60%)

5 months 22 days ago
(06-May-2025)

0/12 (0%)

$3.13 (359.77%)

Hold

$3

$0.29 (10.70%)

$4

6 months 12 days ago
(16-Apr-2025)

9/10 (90%)

$2.05 (215.79%)

89

Buy

$4

$1.29 (47.60%)

7 months 24 days ago
(04-Mar-2025)

1/12 (8.33%)

$2.35 (142.42%)

255

Buy

$4

$1.29 (47.60%)

$7

8 months 18 days ago
(10-Feb-2025)

0/3 (0%)

$2.21 (123.46%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is ESPR (Esperion Therapeutics) average time for price targets to be met?

On average it took 117.75 days on average for the stock forecasts to be realized with a an average price target met ratio 43.29

Which analyst has the current highest performing score on ESPR (Esperion Therapeutics) with a proven track record?

JOEL BEATTY

Which analyst has the most public recommendations on ESPR (Esperion Therapeutics)?

Joel Beatty works at BAIRD and has 4 price targets and 3 ratings on ESPR

Which analyst is the currently most bullish on ESPR (Esperion Therapeutics)?

Chris Shibutani with highest potential upside - $91.29

Which analyst is the currently most reserved on ESPR (Esperion Therapeutics)?

Jason Zemansky with lowest potential downside - -$0.21

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?